Cell membrane permeability
Polyion complex vesicles with cell membrane-permeable peptides address the challenges of genetic modification by enabling stable delivery and expression of functional molecules in plant cells, overcoming environmental concerns and protease degradation.
Patent Information
- Application Number
- JP2021542991
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-08-28
- Filing Date
- 2020-08-27
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2040-08-27
AI Technical Summary
Existing genetic modification techniques for imparting new traits to plants face environmental concerns and challenges in achieving long-term functional expression of introduced molecules due to degradation by intracellular proteases.
Development of polyion complex vesicles (PICsomes) with a cell membrane-permeable peptide on their surface to encapsulate functional molecules, allowing for their delivery and long-term expression within plant cells.
Enables the stable delivery and functional expression of proteins and nucleic acids in plant cells, facilitating genome editing and trait modification without genetic recombination, with improved stability against protease degradation.
Smart Images

Figure 0007578991000005 
Figure 0007578991000006 
Figure 0007578991000007
Abstract
Description
[Technical field]
[0001] The present invention relates to a cell membrane-permeable vesicle, a method for introducing a functional molecule into a cell, and a method for producing a mutant plant. [Background technology]
[0002] In recent years, technologies that impart new traits to plants for the purpose of producing useful substances such as medicines and bioplastics have been attracting attention.
[0003] Genetic modification techniques such as gene recombination have been used as a conventional technique for imparting new traits to plants. However, there are still significant restrictions on the use of genetically modified plants due to concerns about the impact on the environment. Therefore, there is a demand for a technique for modifying plant traits without using genetic recombination techniques.
[0004] There are methods for directly delivering functional molecules such as proteins into plant cells to modify plant traits without relying on genetic modification such as genetic recombination. For example, carrier peptides have been devised to deliver target proteins into plant cells, and fusion peptides combining a cell membrane-permeable sequence and a polycation sequence have been proposed (Patent Document 1).
[0005] The present inventors have succeeded in introducing enzymes into plant cells by conjugating a cell membrane-permeable peptide (CPP) and the enzyme through ionic interactions (Non-Patent Documents 1 and 2). However, it has been difficult to achieve long-term functional expression because the enzyme is decomposed by intracellular proteases. In this context, there is a demand for a technology that can impart traits to plants and enable long-term functional expression. [Prior art documents] [Patent documents]
[0006] [Patent Document 1] International Publication No. 2017 / 126604 [Non-patent literature]
[0007] [Non-Patent Document 1] Ng KK, et al. PLoS One, 2016, 11(4), e0154081. [Non-Patent Document 2] Numata K., et al. Plant Biotechnol (Tokyo), 2016, 33(5), 403-407. Summary of the Invention [Problem to be solved by the invention]
[0008] An object of the present invention is to provide a novel vesicle that is useful for introducing a functional molecule into a plant cell. [Means for solving the problem]
[0009] Polyion complex vesicles (PICsomes), which have been developed for the purpose of medical drug delivery, are capsule-like assemblies formed by the self-assembly of block copolymers and polymers, and functional molecules can be encapsulated inside them (Anraku Y., et al., J. Am. Chem. Soc., 2010, 132, 1631-1636.). PICsomes are semipermeable, and while they are highly permeable to small molecules such as substrates, they are less permeable to relatively large molecules such as proteins. Therefore, if enzyme molecules are introduced into the body while retained inside the PICsome, it is advantageous to be able to express the enzyme function while suppressing the degradation of the enzyme by proteases, etc. (Anraku Y., et al., J. Am. Chem. Soc., 2010, 132, 1631-1636.). Therefore, PICsomes are known to have superior properties as transport carriers for long-term protein function expression compared to micellar complexes. On the other hand, the technology to transport PICsomes into cells or to make them function within cells has not been established.
[0010] As a result of intensive research, the present inventors have produced a cell membrane-permeable vesicle in which a cell membrane-permeable peptide is displayed on the surface of a PICsome, and have found that by encapsulating a protein in the vesicle, the protein is delivered to plant tissues and plant cells and reaches the plant genome, the protein actually functions there, genome editing is possible, and novel traits can be imparted based on the protein. The present invention is based on the above new findings and provides the following (1) to (15) and [1] to [7].
[0011] (1) A cell membrane-permeable vesicle comprising a polyion complex vesicle and a cell membrane-permeable peptide displayed on the surface of the vesicle. (2) The cell membrane-permeable vesicle described in (1), wherein the polyion complex vesicle comprises the following (a) and (b): (a) a polymer comprising a cationic segment, and (b) a block copolymer comprising an anionic segment and an uncharged hydrophilic segment (3) The cell membrane-permeable vesicle described in (1), wherein the polyion complex vesicle is composed of the following (c) and (d): (c) a polymer comprising an anionic segment, and (d) Block copolymers containing cationic segments and uncharged hydrophilic segments (4) The cell membrane-permeable vesicle according to (2) or (3), wherein the cationic segment is formed by linking 3 to 30 cationic amino acid residues, and / or the anionic segment is formed by linking 3 to 30 anionic amino acid residues. (5) The cell membrane-permeable vesicle according to any one of (2) to (4), wherein the cell membrane-permeable peptide is linked to the block copolymer. (6) A cell membrane-permeable vesicle according to any one of (1) to (5), which encapsulates one or more functional molecules. (7) The cell membrane-permeable vesicle described in (6), wherein the functional molecule is a functional peptide and / or a functional nucleic acid. (8) The cell membrane-permeable vesicle according to (6), wherein the functional molecule is a Cas9 protein and a guide RNA molecule for a target gene. (9) A plant, plant tissue, or plant cell comprising the cell membrane-permeable vesicle according to any one of (6) to (8). (10) A method for introducing a functional molecule into a cell, comprising the steps of contacting the cell with a cell membrane-permeable vesicle described in any one of (6) to (8) and applying a physical stimulus to the cell that has come into contact with the cell membrane-permeable vesicle. (11) A method for introducing a mutation into a target gene in a cell, the method comprising the steps of contacting the cell with the cell membrane-permeable vesicle described in (8) and applying a physical stimulus to the cell that has come into contact with the cell membrane-permeable vesicle. (12) The method according to (10) or (11), wherein the cell is a plant cell. (13) The method according to (12), wherein the plant cell is a callus or a true leaf plant cell. (14) A method for producing a mutant plant, comprising the steps of: contacting a plant cell with the cell membrane-permeable vesicle described in (8); introducing the cell membrane-permeable vesicle into the plant cell by applying a physical stimulus to the plant cell that has been in contact with the cell membrane-permeable vesicle, thereby introducing a mutation into a target gene; and obtaining an individual plant from the plant cell into which the mutation has been introduced in the step. (15) A method for preparing a cell membrane-permeable vesicle encapsulating one or more functional molecules, comprising the steps of: constructing a polyion complex vesicle encapsulating the functional molecule by mixing a polymer and a block copolymer in the presence of the functional molecule; and presenting a cell membrane-permeable peptide on the surface of the polyion complex vesicle, wherein the polymer and the block copolymer are a combination of (a) a polymer containing a cationic segment, and (b) a block copolymer containing an anionic segment and an uncharged hydrophilic segment, or (c) a polymer containing an anionic segment, and (d) a block copolymer containing a cationic segment and an uncharged hydrophilic segment.
[0012] [1] A vesicle formed from a polymer having a positively charged segment and a block copolymer having a nonionic, uncharged hydrophilic segment and a negatively charged segment, the vesicle having a peptide containing a cell membrane-permeable sequence on its membrane. [2] A vesicle formed from a polymer having a negatively charged segment and a block copolymer having a nonionic, uncharged hydrophilic segment and a positively charged segment, the vesicle having a peptide containing a cell membrane-permeable sequence on its membrane. [3] A vesicle according to [1] or [2], which encapsulates at least one type of protein. [4] A composition comprising a vesicle (preferably a polyion complex vesicle) that encapsulates a protein and has a peptide containing a cell membrane-permeable sequence on at least a portion of its surface. [5] A composition comprising a vesicle (preferably a polyion complex vesicle) encapsulating a protein and having a reactive group on at least a portion of its surface. [6] The vesicle or composition according to any of [1] to [4], wherein the vesicle is a polyion complex vesicle comprising a cationic component comprising at least one kind of oligo- or polypeptide (hereinafter sometimes referred to as a "cationic segment") having 3 or more (3 or more and 30 or less, 3 or more and 20 or less, 3 or more and 15 or less, or 3 or more and 10 or less) cationic amino acids (including both natural and non-natural cationic amino acids) having a cationic group (e.g., an amino group) in the side chain, and an anionic component comprising at least one kind of oligo- or polypeptide (including both natural and non-natural cationic amino acids) having 3 or more (3 or more and 30 or less, 3 or more and 20 or less, 3 or more and 15 or less, or 3 or more and 10 or less) anionic amino acid (including both natural and non-natural cationic amino acids) having an anionic group (e.g., a carboxyl group) in the side chain. [7] A method for introducing a protein into a plant cell, comprising contacting the plant cell with the vesicle described in [3] or the composition described in [4].
[0013] This specification incorporates the disclosure of U.S. patent application Ser. No. 62 / 892,775, from which this application claims priority. Effect of the Invention
[0014] According to the present invention, it is possible to provide a novel vesicle that is useful for introducing a functional molecule into a plant cell. [Brief description of the drawings]
[0015] [Figure 1] This is a schematic diagram showing the conferring of new traits to plants by introducing PICsomes that display cell membrane permeability on their surface. In the figure, "PolyLys" indicates the structure of the lysine (Lys) unit. [Diagram 2] FIG. 1 shows the increase in particle size over time of aggregates composed of cationic block copolymer Alkyne-TEG-bP(Lys)-OMe and anionic block copolymer Alkyne-TEG-bP(Lys(COOH))-OMe. [Diagram 3] This is a field emission scanning electron microscope (FE-SEM) image of an aggregate composed of the cationic block copolymer Alkyne-TEG-bP(Lys)-OMe and the anionic block copolymer Alkyne-TEG-bP(Lys(COOH))-OMe. The aggregate had a spherical shape (left), but when irradiated with an electron beam, the surface of the spherical aggregate was destroyed and internal cavities were confirmed (right). [Figure 4] FIG. 1 shows the results of stable maintenance of particle size of aggregates composed of cationic polymer PolyLys and anionic block copolymer Alkyne-TEG-bP(Lys(COOH))-OMe. [Diagram 5](A) Rhodamine-labeled NPT II not encapsulated in a cell-permeable vesicle was introduced into an Arabidopsis root hair, and the result was observed by confocal laser scanning microscopy (CLSM). (B) Rhodamine-labeled NPT II encapsulated in a cell-permeable vesicle was introduced into an Arabidopsis root hair, and the result was observed by confocal laser scanning microscopy. The arrows indicate the red fluorescence derived from rhodamine. The images shown at the top and right of the panels (a and b) show the cross-section of the root hair at the position indicated by the arrowhead. [Figure 6] Figure 1 shows examples of mutations induced at the target cleavage site by introducing Cas9-guide RNA complexes into Arabidopsis hypocotyl-derived calli (a) to (c). In the figure, "PAM" stands for protospacer adjacent motif, and "target sequence" stands for the position of the sequence recognized by the guide RNA. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0016] 1. Cell membrane permeable vesicles 1-1. Overview The first aspect of the present invention is a cell membrane-permeable vesicle. The cell membrane-permeable vesicle of the present invention includes a polyion complex vesicle and a cell membrane-permeable peptide displayed on its surface, and can encapsulate one or more functional molecules. According to the cell membrane-permeable vesicle of the present invention, the functional molecule can be introduced into a cell and made to function.
[0017] 1-2.Definition of Terms Terms frequently used in this specification are defined below. As used herein, the term "polyion complex vesicle (PICsome)" refers to an assembly formed by self-assembly of charged block copolymers, polymers, etc. The polyion complex vesicle is a capsule-like assembly that can encapsulate functional molecules inside.
[0018] As used herein, the term "cell permeating peptide (CPP)" refers to a peptide that has the ability to permeate cell membranes. Examples of cell-penetrating peptides include BP100 (Appl Environ Microbiol 72 (5), 3302, 2006), HIV Tat (Journal Biological Chemistry, 272, pp.16010-16017, 1997), Tat2 (Biochim Biophys Acta 1768 (3), 419, 2007), Penetratin, pVEC, pAntp (Journal Biological Chemistry, 269, pp.10444-10450, 1994), HSV-1 VP22 (Cell, 88, pp.223-233, 1997), MAP (Model amphiphilic peptide) (Biochimica Biophysica Acta, 1414, pp.127-139, Examples of such polypeptides include, but are not limited to, IFN-γ (FEBS Journal, 12, pp.67-77, 1998), Transportan (FEBS Journal, 12, pp.67-77, 1998), R7 (Nature Medicine, 6, pp.1253-1257, 2000), MPG (Nucleic Acid Research 25, pp.2730-2736, 1997), and Pep-1 (Nature Biotechnology, 19, pp.1173-1176, 2001).
[0019] Specific examples of cell permeable sequences include the following sequences: KKLFKKILKYL (SEQ ID NO: 1), RKKRRQRRRRKKRRQRRR (SEQ ID NO: 2), RKKRRQRRR (SEQ ID NO: 3), PLSSIFSRIGDP (SEQ ID NO: 4), PISSIFSRTGDP (SEQ ID NO: 5), AISSILSKTGDP (SEQ ID NO: 6), PILSIFSKIGDL (SEQ ID NO: 7), PLSSIFSKIGDP (SEQ ID NO: 8), PLSSIFSHIGDP (SEQ ID NO: 9), PLSSIFSSIGDP (SEQ ID NO: 10), RQIKIWFQNRRMKWKK (SEQ ID NO: 11), DAATATRGRSAASRPTERPRAPARSASRPR Examples of such peptides include RPVD (SEQ ID NO: 12), AAVALLPAVLLALLAP (SEQ ID NO: 13), AAVLLPVLLAAP (SEQ ID NO: 14), VTVLALGALAGVGVG (SEQ ID NO: 15), GALFLGWLGAAGSTMGA (SEQ ID NO: 16), MGLGLHLLVLAAALQGA (SEQ ID NO: 17), LGTYTQDFNKFHTFPQTAIGVGAP (SEQ ID NO: 18), GWTLNSAGYLLKINLKALAALAKKIL (SEQ ID NO: 19), KLALKLALKALKAALKLA (SEQ ID NO: 20), and (Lys-Aib-Ala)3 (Aib represents 2-aminoisobutyric acid) (SEQ ID NO: 78). In some cases, peptide sequences in which one to several amino acid residues contained in these peptide sequences are substituted, inserted, and / or deleted and which have cell permeability can be preferably used. In this specification, "several" means, for example, 10 or less, 9 or less, 8 or less, 7 or less, 6 or less, preferably 5 or less or 4 or less, and more preferably 3 or less or 2 or less.
[0020] In addition to the sequences listed above, examples of cell-penetrating sequences that can be used are shown in Table 1 below. [Table 1] TIFF0007578991000002.tif155164
[0021] Details of the references listed in Table 1 are as follows: TIFF0007578991000003.tif240168TIFF0007578991000004.tif194167
[0022] In one embodiment, the cell-permeable sequence includes an amino acid sequence selected from the group consisting of the amino acid sequences shown in SEQ ID NOs: 1 to 72, or a sequence in which one to several amino acid residues contained in these amino acid sequences have been substituted, inserted, and / or deleted and which has cell-permeability.
[0023] In one embodiment, the cell-permeable sequence comprises the amino acid sequence of Tat (SEQ ID NO: 33), or a sequence in which one to several amino acid residues contained in the amino acid sequence have been substituted, inserted, and / or deleted and which has cell-permeability.
[0024] As the cell-penetrating peptide, two or more kinds of cell-penetrating peptides may be used in combination. It is also possible to select a cell-penetrating peptide specific to a particular cell of interest.
[0025] As used herein, the term "cell membrane-permeable vesicle" refers to a vesicle that has the property of being able to permeate a cell membrane, such as a vesicle that displays a cell membrane-permeable peptide on its surface.
[0026] As used herein, the term "block copolymer" refers to a polymer that contains chains of two or more different polymers covalently linked together.
[0027] As used herein, the term "cationic segment" or "cationic segment" refers to a positively charged segment.
[0028] As used herein, the term "anionic segment" or "anionic segment" refers to a negatively charged segment.
[0029] As used herein, the term "uncharged hydrophilic segment" refers to a hydrophilic segment that is not charged.
[0030] As used herein, the term "cationic amino acid" refers to an amino acid having a positively charged side chain (cationic side chain), such as a side chain having an amino group or a guanidino group. The cationic amino acid may be a basic amino acid. The cationic amino acid may be either a natural or non-natural cationic amino acid. Specific examples of cationic amino acids include lysine (Lys / K), arginine (Arg / R), succinyl lysine, malonyl lysine, glutaryl lysine, and ornithine.
[0031] As used herein, the term "anionic amino acid residue" refers to an amino acid having a negatively charged side chain (anionic side chain), such as a side chain having a carboxyl group. The anionic amino acid may be an acidic amino acid. The anionic amino acid may be either a natural or non-natural anionic amino acid. Specific examples of anionic amino acids include aspartic acid (Asp / D), glutamic acid (Glu / E), cysteic acid, phosphoserine, and carboxylated lysine.
[0032] As used herein, the term "peptide" refers to an amino acid polymer having one or more peptide bonds. The term "peptide" is not limited by the number of amino acid residues contained in the peptide. Thus, "peptide" includes oligopeptides containing two or more to several amino acid residues, such as dipeptides and tripeptides, to polypeptides containing many amino acid residues. Thus, it includes not only so-called proteins, but also fragments and peptides linked to other peptides by peptide bonds.
[0033] As used herein, the term "genome editing protein" refers to a protein used in genome editing. In particular, it refers to a site-specific nuclease used in genome editing. Examples include restriction enzymes, zinc finger nucleases (ZFNs), TALE nucleases (TALENs), CRISPR / Cas9, and CRISPR / Cpf1 (Cas12a). As the Cas9 protein, but is not limited to, spCas9 protein derived from Streptococcus pyogenes and saCas9 protein derived from Staphylococcus aureus can be used.
[0034] As used herein, the term "guide RNA (gRNA)" refers to an RNA that guides the Cas9 protein, Cpf1 protein, etc., to a target DNA sequence on the genome in genome editing using CRISPR. Specifically, the gRNA of Cas9 may be composed of a crRNA (CRISPR RNA) that recognizes a target DNA sequence of about 20 bases (in the case of the Cpf1 protein, only the crRNA functions as gRNA), or may be composed of two types of RNA molecules, the crRNA and the tracrRNA (trans-activating crRNA) that serves as a scaffold for binding to Cas9, and may be exemplified by sgRNA (single guide RNA) that combines these together.
[0035] 1-3.Configuration The cell membrane-permeable vesicle of the present invention will be specifically described below. The cell membrane-permeable vesicle of the present invention contains a polyion complex vesicle (PICsome) as an essential component, and a cell membrane-permeable peptide displayed on its surface, and can encapsulate one or more functional molecules as optional components.
[0036] (1) Polyion complex vesicle (PICsome) The type of PICsome contained in the cell membrane-permeable vesicle of the present invention is not limited. In one embodiment, the PICsome contained in the cell membrane permeable vesicle of the present invention is (a) a polymer comprising a cationic segment, and (b) a block copolymer comprising an anionic segment and an uncharged hydrophilic segment may include:
[0037] In another embodiment, the PICsome contained in the cell membrane-permeable vesicle of the present invention is (c) a polymer comprising an anionic segment, and (d) Block copolymers containing cationic segments and uncharged hydrophilic segments may include:
[0038] In a further embodiment, the PICsome contained in the cell membrane-permeable vesicle of the present invention is (b) a block copolymer comprising an anionic segment and an uncharged hydrophilic segment; and (d) Block copolymers containing cationic segments and uncharged hydrophilic segments may include:
[0039] (1-1) Cationic segment The cationic segment is not limited, and may be, for example, a cationic segment formed by linking 3 or more, 3 to 30, 3 to 20, 3 to 15, or 3 to 10 cationic amino acid residues, for example, 3, 4, 5, 6, 7, or 8 cationic amino acid residues.
[0040] (1-2) Anionic segment The anionic segment is not limited, and may be, for example, a segment formed by linking 3 or more, 3 to 30, 3 to 20, 3 to 15, or 3 to 10 anionic amino acid residues, for example, 3, 4, 5, 6, 7, or 8 anionic amino acid residues.
[0041] The combination of the number of cationic amino acid residues in the cationic segment and the number of anionic amino acid residues in the anionic segment may be any combination within the above ranges. For example, the cationic segment may be formed by linking 3 to 30 cationic amino acid residues, and / or the anionic segment may be formed by linking 3 to 30 anionic amino acid residues.
[0042] Examples of the above (a), (b), (c), and (d) include, but are not limited to, (a) polylysine (PolyLys or P(Lys)), (b) Alkyne-TEG-bP(Lys(COOH))-OMe, (c) P(Lys(COOH)), and (d) Alkyne-TEG-bP(Lys)-OMe.
[0043] (1-3) Uncharged hydrophilic segment The uncharged hydrophilic segment is not limited. For example, the uncharged hydrophilic segment may contain an ethylene glycol residue. The number of polyethylene glycol residues contained in the uncharged hydrophilic segment is preferably 2 or more, 2 or more and 10 or less, or 2 or more and 6 or less. From the viewpoint of vesicle stability, the molecular weight of the uncharged hydrophilic segment is preferably 1,000 or less. In one embodiment, the polyethylene glycol is tetraethylene glycol (TEG).
[0044] (2) Cell membrane-penetrating peptides In addition, the type of cell membrane-permeable peptide contained in the cell membrane-permeable vesicle of the present invention is not limited, and any cell membrane-permeable peptide can be used. For example, BP100 peptide, BP100(KH)9 peptide, BP100CH7 peptide, KAibA peptide, etc. may be used.
[0045] In the present invention, the mode of presentation of the cell membrane-permeable peptide on the PICsome surface is not limited. For example, the cell membrane-permeable peptide may be bound to any component constituting the PICsome. The term "bond" as used herein is not limited, and may be, for example, a covalent bond or a supramolecular interaction. The covalent bond is not limited, and includes, for example, a peptide bond, a disulfide bond, a bond via a triazole ring formed by a click reaction, and a bond via a succinimide formed by a reaction of a thiol with a maleimide. The "supramolecular interaction" is not limited as long as it is a non-covalent interaction between molecules, and examples thereof include a hydrogen bond, a hydrophobic interaction or hydrophobic bond, an electrostatic interaction or an ionic bond, a salt bridge, and a coordinate bond.
[0046] In addition, the components of the PICsome to which the cell membrane-penetrating peptide is bound are not limited, so long as the cell membrane-penetrating peptide can be presented on the PICsome surface. For example, the cell membrane-penetrating peptide may be bound to any of a polymer containing a cationic segment, a block copolymer containing an anionic segment and an uncharged hydrophilic segment, a polymer containing an anionic segment, and / or a block copolymer containing a cationic segment and an uncharged hydrophilic segment. The position to which the cell membrane-penetrating peptide is bound in these molecules is not limited, but it may be bound to the ends of the molecule, for example, one end or both ends. The number of cell membrane-penetrating peptides bound is not limited, but for example, one cell membrane-penetrating peptide may be bound per molecule.
[0047] (3)Functional molecules The functional molecule encapsulated in the cell membrane permeable vesicle is not limited. For example, it may be a peptide, a polysaccharide, a nucleic acid, a compound, or a mixture thereof. In one embodiment, the functional molecule is a functional peptide and / or a functional nucleic acid.
[0048] In the present invention, the term "functional peptide" refers to a peptide having a specific biological function in or outside a living body, or inside or outside a cell. In the present specification, the term "specific biological function" is not limited to any function that can have any effect on a biomolecule such as a protein or a nucleic acid, a cell, a tissue, or an individual. The specific biological function may be natural or non-natural, and examples thereof include a cell adhesion function, a signal transduction function, a binding function, a linking function, a labeling function, and a metabolic function. The linking function corresponds to a function of linking a biomolecule such as another peptide or a nucleic acid having a specific biological function, a low molecular weight compound, or a metal ion. Examples of the linking function include a function of mediating antigen-antibody binding or receptor-ligand interaction, a function of binding a biomolecule such as RNA and / or DNA, and a function of binding nickel ions, copper ions, and the like. The labeling function corresponds to a function of labeling a biomolecule such as a protein or a nucleic acid, a cell, a tissue, and an individual. Examples of the labeling function include a fluorescent label and an epitope label. The metabolic function includes a genome editing function such as nuclease activity. The functional peptide can be appropriately selected according to the purpose of use.
[0049] In the present invention, specific examples of the "functional peptide" include enzymes, binding proteins, marker proteins, and artificial peptides, as well as peptide fragments thereof. The "enzyme" may be, but is not limited to, a genome editing protein, for example, a nuclease such as a Cas9 protein. The "binding protein" is a protein that specifically binds to a specific molecule. Examples include, but are not limited to, an antibody or antibody fragment or antigen that mediates antigen-antibody binding, (strept)avidin, maltose-binding protein (MBP), a receptor or ligand that mediates receptor-ligand interaction, a DNA-binding protein, and an RNA-binding protein. The "marker protein" is a protein that can be used as a label when detecting cells, proteins, and the like. Usually, a polypeptide that can determine the expression or presence of a target protein based on its activity corresponds to this. Examples include, but are not limited to, fluorescent proteins such as GFP, luminescent proteins such as luciferin or aequorin, and enzymes such as horseradish peroxidase (HRP) or alkaline phosphatase (AP). The "artificial peptide" is also called a tag peptide, and is an oligopeptide that is artificially synthesized and consists of several to a dozen amino acids.
[0050] The "functional nucleic acid" may be any of a guide RNA molecule, an antisense nucleic acid (ASO), an siRNA, an miRNA, and an aptamer. The nucleic acid constituting the functional nucleic acid may be either natural or non-natural.
[0051] In one embodiment, the functional molecule may be a Cas9 protein and a guide RNA molecule for a target gene.
[0052] The cationic segment and the anionic segment may be mixed in any ratio that allows the formation of a PICsome. For example, they may be mixed in such a ratio that the positive and negative charges are offset. For example, the cationic segment and the anionic segment may be peptides that contain or consist of natural or unnatural amino acid residues having monovalent cationic and anionic groups in their side chains, respectively, and may be mixed in such a molar ratio that the average degree of polymerization of each is 1:1.
[0053] In one embodiment, crosslinks may be formed between anionic segments, cationic segments, and / or between anionic and cationic segments forming the PICsome, for example, by a side chain crosslinking reaction using carbodiimides such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) as a crosslinking agent.
[0054] 1-4.Effects According to the cell membrane-permeable vesicle of the present invention, functional molecules such as proteins can be delivered into cells such as plant cells, and new traits can be imparted to individuals such as plants. For example, it is possible to introduce a mutation by delivering a genome editing protein to a cell and allowing it to function in the nucleus.
[0055] The functional molecule encapsulated in the cell membrane-permeable vesicle of the present invention can function stably for a long period of time while remaining encapsulated in the cell membrane-permeable vesicle and protected from proteases and the like after the cell membrane-permeable vesicle is transferred into the cell.
[0056] Alternatively, the functional molecule encapsulated in the cell membrane permeable vesicle of the present invention can function in a state where a part or all of the functional molecule is released from the cell membrane permeable vesicle after the cell membrane permeable vesicle is transferred into the cell. For example, when the functional molecule is a genome editing protein, the genome editing protein can be released from the cell membrane permeable vesicle and recognize the target gene sequence on the genome. When the functional molecule is a functional nucleic acid such as siRNA or miRNA, the functional nucleic acid is released from the cell membrane permeable vesicle and induces degradation of the target mRNA or translation suppression by RNAi (RNA interference).
[0057] The stability of the PICsome is improved when an uncharged hydrophilic segment is located at the end of only one of the cationic and anionic segments.
[0058] According to the cell membrane-permeable vesicle of the present invention, there is also provided a composition comprising the cell membrane-permeable vesicle of the present invention.
[0059] 2. Plants, plant tissues, or plant cells containing cell membrane-permeable vesicles 2-1. Overview A second aspect of the present invention is a plant, plant tissue, or plant cell comprising the cell membrane-permeable vesicle of the present invention. The plant, plant tissue, or plant cell of this aspect has a novel trait based on the functional molecule encapsulated in the cell membrane-permeable vesicle.
[0060] 2-2.Configuration (1) Cell membrane permeable vesicles The cell membrane-permeable vesicle contained in the plant, plant tissue, or plant cell of this embodiment encapsulates one or more functional molecules. The configurations of the cell membrane-permeable vesicle and the functional molecules have already been described in detail in the first embodiment, so a detailed description thereof will be omitted here.
[0061] (2) Plants, plant tissues, or plant cells The types of plants, plant tissues, and plant cells in this embodiment are not limited. The plant is not particularly limited, and may be either angiosperm or gymnosperm. Angiosperms include both dicotyledonous and monocotyledonous plants. Representative plants include important plants in agriculture, particularly in the seed and floriculture industries, such as crop plants such as grains, flowers, vegetables, and fruits. Specifically, dicotyledonous plants include species belonging to the Brassicaceae family (e.g., cabbage, radish, Chinese cabbage, and rapeseed), species belonging to the Fabaceae family (e.g., soybean, peanut, pea, kidney bean, adzuki bean, broad bean, and sweet pea), species belonging to the Solanaceae family (e.g., tomato, eggplant, potato, tobacco, bell pepper, capsicum, and petunia), species belonging to the Rosaceae family (e.g., strawberry, rose, apple, pear, peach, loquat, almond, plum, plum, and cherry), and species belonging to the Orchidaceae family (e.g., Cymbidium , Phalaenopsis, Cattleya, Dendrobium), species belonging to the Liliaceae family (e.g., lily, tulip, hyacinth, muscari, leek, onion, garlic), Rutaceae family (e.g., mandarin orange, orange, grapefruit, lemon, yuzu), species belonging to the Vitaceae family (e.g., grape), species belonging to the Asteraceae family (e.g., lettuce, chrysanthemum, dahlia, margaret, sunflower), species belonging to the Caryophyllaceae family (e.g., carnation, gypsophila), species belonging to the Theaceae family (e.g., sasanqua, tea plant). In addition, as for monocotyledonous plants, species belonging to the Poaceae family (e.g., rice, wheat, barley, corn, sugar cane, sorghum, sorghum) are included.
[0062] The plant tissue is not particularly limited, and specifically may be any organ (e.g., roots, root hairs, stems, leaves, flowers, epidermis, or combinations thereof, or pollen, sprouts, egg cells, seeds, etc.), tissue consisting of a group of morphologically and / or functionally differentiated cells, or a part thereof. The plant cells used may be any cell type contained in the above-mentioned plant tissues.
[0063] 3. Methods for introducing functional molecules into cells 3-1. Overview A third aspect of the present invention is a method for introducing a functional molecule into a cell. The method of this embodiment includes a step of contacting a cell with a cell membrane-permeable vesicle (contact step), and a step of applying a physical stimulus to the cell that has come into contact with the cell membrane-permeable vesicle (physical stimulus step).
[0064] In the method of this embodiment, the cell membrane-permeable vesicle that has come into contact with the cell in the contact step is promoted to permeate the cell membrane and migrate into the cell by the physical stimulation step, and can deliver functional molecules such as peptides into the cell.
[0065] 3-2. Method The method of this embodiment includes a step of contacting a cell with a cell membrane-permeable vesicle (contact step), and a step of applying a physical stimulus to the cell that has come into contact with the cell membrane-permeable vesicle (physical stimulus step).
[0066] The target cells to which functional molecules are introduced by the cell membrane-permeable vesicle of the present invention are not particularly limited. Any cell of eukaryotes, bacteria, or archaea is the target. The eukaryote may be a unicellular or multicellular organism, and may be either an animal cell or a plant cell. Preferably, the target is an animal cell or a plant cell. The plant cell may be any cell of the plant species described in the second aspect, or any cell of the plant tissue described in the second aspect. For example, the plant cell may be a callus or a true leaf plant cell. The animal cell may be a non-human cell, or a cell derived from a human and located outside the human body (e.g., a cell isolated from a human).
[0067] In this embodiment, the cell-permeable vesicle introduced into the cell encapsulates one or more functional molecules. The configurations of the cell-permeable vesicle and the functional molecules have already been described in detail in the first embodiment, and therefore, detailed description thereof will be omitted here.
[0068] 3-2-1. Process (1) Contact process The contact step is not particularly limited as long as it is a step that can bring cells into contact with the cell membrane-permeable vesicle. For example, the contact step may be a step of mixing, suspending, or immersing cells, tissues containing cells, or individuals containing cells in an aqueous solution containing the cell membrane-permeable vesicle, or a step of spraying, applying, or administering an aqueous solution containing the cell membrane-permeable vesicle to cells, tissues containing cells, or individuals containing cells.
[0069] (2) Physical stimulation process The physical stimulation step is not limited as long as it can promote the permeation of the cell membrane of the cell membrane-permeable vesicle that has come into contact with the cell in the contact step and its transfer into the cell. The physical stimulation is preferably a stimulation that can increase the permeability of the cell membrane. For example, pressure changes such as pressurization and / or depressurization, temperature changes such as heating and / or cooling, freezing and / or thawing, temperature stimulation such as heat shock, drying, cutting, UV irradiation or X-ray irradiation, ultrasonic irradiation, microwave irradiation, or osmotic pressure change can be used.
[0070] 4. Method for introducing mutations into target genes in cells A fourth aspect of the present invention is a method for introducing a mutation into a target gene in a cell. The method of this embodiment includes a step of contacting a cell with a cell membrane-permeable vesicle (contact step), and a step of applying a physical stimulus to the cell that has come into contact with the cell membrane-permeable vesicle (physical stimulus step).
[0071] The cell membrane-permeable vesicle used in this embodiment contains a functional peptide and / or a functional nucleic acid as a functional molecule. More specifically, in this embodiment, the functional molecule is a genome editing tool such as a genome editing protein. For example, it is a Cas9 protein and a guide RNA molecule for a target gene. The other configurations of the cell membrane-permeable vesicle are similar to those of the first embodiment.
[0072] Moreover, the target cells, the contact step, and the physical stimulation step are configured as described in the third embodiment.
[0073] According to the method of this embodiment, the cell membrane-permeable vesicle that has come into contact with the cell in the contact step is promoted to permeate the cell membrane and migrate into the cell by the physical stimulation step, and genome editing tools such as Cas9 protein and guide RNA molecules for the target gene are delivered into the cell, thereby causing mutations.
[0074] 5. Methods for generating mutant plants A fifth aspect of the invention is a method for producing a mutant plant. The method of this embodiment includes a step of contacting a cell with a cell membrane-permeable vesicle (contact step), a step of introducing the cell membrane-permeable vesicle into the plant cell by applying a physical stimulus to the plant cell that has been contacted with the cell membrane-permeable vesicle, thereby introducing a mutation into the target gene (mutation introduction step), and a step of obtaining a plant individual from the plant cell into which the mutation has been introduced.
[0075] The configuration of the cell membrane-permeable vesicle used in this embodiment, the target cells, and the contact step are the same as those in the fourth embodiment. The mutation introduction step in this embodiment includes the physical stimulation step in the fourth embodiment. Preferred functional molecules encapsulated in the cell membrane-permeable vesicle introduced into the cell in this embodiment include a genome editing protein, a Cas9 protein, and a guide RNA molecule for a target gene.
[0076] The step of obtaining a plant individual is not particularly limited. In one embodiment, a plant body can be regenerated by obtaining seeds from an individual containing a cell into which a mutation has been introduced in the mutation introduction step. In another embodiment, a dedifferentiated cell (e.g., callus cell) can be obtained by inducing dedifferentiation (e.g., callus induction) as necessary for a part or all of a cell, a tissue containing a cell, or an individual containing a cell into which a mutation has been introduced in the mutation introduction step, and a plant body can be regenerated by inducing redifferentiation of the dedifferentiated cell or callus. In this case, any method known in the art can be used for the dedifferentiation induction treatment method. Examples of the method that can be used include, but are not limited to, plant hormones, temperature stimulation such as heat shock, injury such as cutting treatment, and infection with viruses or bacteria. In addition, the method of inducing redifferentiation is not limited, and examples thereof include a method using a plant hormone.
[0077] According to the method of this embodiment, the cell membrane-permeable vesicle that has come into contact with the cell in the contact step is promoted to permeate the cell membrane and migrate into the cell by the mutation introduction step, and genome editing tools such as Cas9 protein and guide RNA molecules for the target gene are delivered into the cell, causing a mutation in the target gene in the genome, thereby producing a mutant plant.
[0078] 6. Preparation of cell membrane permeable vesicles 6-1. Overview A sixth aspect of the present invention is a method for preparing a cell membrane-permeable vesicle. According to the method of this aspect, it is possible to prepare a vesicle that encapsulates one or more functional molecules and presents a cell membrane-permeable peptide on its surface.
[0079] 6-2. Method The method of this embodiment is a method for preparing a cell membrane-permeable vesicle encapsulating one or more functional molecules. The method of this embodiment includes, as essential steps, a step of constructing a polyion complex vesicle encapsulating a functional molecule by mixing a polymer and / or a block copolymer in the presence of the functional molecule (PICsome construction step), and a step of presenting a cell membrane-permeable peptide on the surface of the polyion complex vesicle (cell membrane-permeable peptide presentation step), and includes, as an optional step, a step of crosslinking the PICsome (crosslinking step). The configurations of the functional molecule and the cell membrane-permeable peptide in this embodiment are similar to those in the first embodiment.
[0080] 6-2-1. Process (1)PICsome construction process The combinations of polymers and / or block copolymers to be mixed in the presence of functional molecules in the PICsome construction process are the following (1) to (3): (1) a combination of (a) a polymer comprising a cationic segment, and (b) a block copolymer comprising an anionic segment and an uncharged hydrophilic segment; (2) (c) a combination of a polymer containing an anionic segment and (d) a block copolymer containing a cationic segment and an uncharged hydrophilic segment; or (3) (b) a block copolymer comprising an anionic segment and an uncharged hydrophilic segment, and (d) a combination of a block copolymer comprising a cationic segment and an uncharged hydrophilic segment. The above formula is selected from the following formula:
[0081] The configurations of the cationic segment, the anionic segment, and the uncharged hydrophilic segment are the same as those in the first embodiment. These segments can be synthesized, for example, by enzymatic polymerization using papain.
[0082] The cationic segment and the anionic segment may be mixed in any ratio that allows the formation of a PICsome. For example, they may be mixed in such a ratio that the positive and negative charges are offset. For example, the cationic segment and the anionic segment may be peptides that contain or consist of natural or unnatural amino acid residues having monovalent cationic and anionic groups in their side chains, respectively, and may be mixed in such a molar ratio that the average degree of polymerization of each is 1:1.
[0083] The polymer and / or block copolymer mixed in this step preferably has a modifying group capable of binding the cell membrane-permeable peptide presented in the cell membrane-permeable peptide presentation step.
[0084] In one embodiment, the polymer and / or block copolymer may include an alkyne or azide as a modifying group to which a cell membrane penetrating peptide may be attached via click chemistry.
[0085] (2) Cell membrane permeable peptide presentation process In this embodiment, the mode of presentation of the cell membrane-permeable peptide on the PICsome surface is not limited.
[0086] It is preferable that the cell membrane-permeable peptide presented in this process has a modifying group capable of binding to the PICsome constructed in the PICsome construction process, for example, a modifying group capable of binding to the polymer and / or block copolymer contained in the PICsome.
[0087] In one embodiment, the modifying group may be an alkyne or azide that may be attached to the polymer and / or block copolymer by click chemistry. For example, the cell membrane-penetrating peptide may have an azide group and the polymer and / or block copolymer contained in the PICsome may have an alkynyl group. Alternatively, the cell membrane-penetrating peptide may have an alkynyl group and the polymer and / or block copolymer contained in the PICsome may have an azide group. In this case, the cell membrane-penetrating peptide can be attached to the polymer and / or block copolymer by forming a triazole ring between the alkyne and azide using a click reaction.
[0088] As the conditions for the click reaction for binding the cell membrane-permeable peptide to the polymer and / or block copolymer, any known conditions can be used.
[0089] (3) Crosslinking process The crosslinking step of crosslinking a PICsome is a step of crosslinking some or all of the components contained in the PICsome. This step is a selective step, and can be carried out between the PICsome construction step and the cell membrane-permeable peptide display step, after the cell membrane-permeable peptide display step, and / or simultaneously with the cell membrane-permeable peptide display step.
[0090] The method for crosslinking PICsomes is not limited as long as it is a method capable of crosslinking the components that constitute PICsomes. For example, a condensation reaction of the polymer side chains can be carried out using carbodiimides such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) as a crosslinking agent.
[0091] The crosslinking in this process can occur between polymers, between block copolymers, and / or between polymers and block copolymers contained in the PICsome, for example, between anionic segments, between cationic segments, and / or between anionic and cationic segments.
[0092] This step can improve the stability of the cell membrane-permeable vesicles obtained by the method of this embodiment.
[0093] One embodiment of the present invention is shown in FIG. 1. A PICsome having an alkyne on its surface is constructed by mixing Alkyne-TEG-bP(Lys-(COOH))-OMe, which is a block copolymer having an alkyne, and Alkyne-TEG-bP(Lys)-OMe or PolyLys having no TEG, and a protein is mixed during or after the construction of the PICsome. An aqueous solvent can be used for the mixing. This makes it possible to obtain a PICsome encapsulating a protein. Next, a cell membrane-permeable peptide (N3-BP-100) having an azide group is prepared and reacted with an alkynyl group on the vesicle surface by click chemistry to obtain a cell membrane-permeable vesicle having a cell membrane-permeable sequence BP-100 on its surface. The cell membrane-permeable vesicle thus obtained can be introduced into a cell (FIG. 1). EXAMPLES
[0094] Example 1: Preparation of an aggregate composed of Alkyne-TEG-bP(Lys)-OMe and Alkyne-TEG-bP(Lys(COOH))-OMe (the purpose) A conjugate composed of Alkyne-TEG-bP(Lys)-OMe and Alkyne-TEG-bP(Lys(COOH))-OMe is prepared.
[0095] (method) (1) Synthesis of cationic block copolymer Alkyne-TEG-bP(Lys)-OMe, cationic polymer PolyLys, and anionic block copolymer Alkyne-TEG-bP(Lys(COOH))-OMe Polylysine P(Lys-(Boc))-OMe, whose side chains are protected by Boc groups, was synthesized by enzymatic polymerization using papain. The number of repeating lysine residues in polylysine is approximately 5 to 7. Alkyne-TEG-bP(Lys-(Boc))-OMe was synthesized by linking this with tetraethylene glycol (TEG) having an alkyne using succinic anhydride. The Boc groups in the side chains of this block copolymer were deprotected with TFA, and then TEA was added and dialyzed to obtain cationic block copolymer Alkyne-TEG-bP(Lys)-OMe and cationic polymer PolyLys. In addition, the side chains of the obtained cationic block copolymer were reacted with succinic anhydride to synthesize anionic block copolymer Alkyne-TEG-bP(Lys(COOH))-OMe. The synthesized polymer was characterized by NMR and MALDI-TOF MS.
[0096] (2) Preparation of PICsome The obtained polymers were each dissolved in MilliQ water. The solutions were mixed 1:1 and stirred for 10 seconds in a Vortex mixer to prepare PICsomes.
[0097] (3) Particle size evaluation and morphological observation of PICsomes The particle size of the resulting PICsomes was evaluated using dynamic light scattering (DLS) measurements. In addition, the PICsome solution was dropped onto a silicon wafer, dried under reduced pressure, and the assembly morphology was observed using a field emission scanning electron microscope (FE-SEM).
[0098] (result) A 0.1 mM Alkyne-TEG-bP(Lys)-OMe solution and a 0.1 mM Alkyne-TEG-bP(Lys(COOH))-OMe solution were mixed and left to stand for 10 minutes, after which dynamic light scattering (DLS) measurements were performed. As a result, the formation of aggregates with a particle size of about 200 nm was confirmed (Figure 2, about 0 hours).
[0099] Next, the morphology of the aggregates was evaluated using a field emission scanning electron microscope. As a result, it was found that the aggregates had a spherical morphology (Fig. 3, left photo). Furthermore, it was confirmed that the surface of the spherical aggregates was destroyed by electron beam irradiation during electron microscope observation, resulting in hollow interiors (Fig. 3, right photo).
[0100] These results demonstrated that capsule-shaped particles, called PICsomes, with internal cavities were formed in a mixed solution of Alkyne-TEG-bP(Lys)-OMe and Alkyne-TEG-bP(Lys(COOH))-OMe.
[0101] Next, the morphology of the aggregates was observed over time. As a result, after mixing an aqueous solution of Alkyne-TEG-bP(Lys)-OMe with an aqueous solution of Alkyne-TEG-bP(Lys(COOH))-OMe, aggregates of about 200 nm were formed (Fig. 2, about 0 h). The particle size increased over time, reaching about 1500 nm after 12 h (Fig. 2, 12 h). This was thought to be because the two types of block copolymers used to form the aggregates contained TEG, and the aggregates were destabilized due to steric repulsion between TEGs, and the PICsomes merged with each other over time to form larger aggregates.
[0102] <Example 2: Preparation and crosslinking of an assembly composed of PolyLys and Alkyne-TEG-bP(Lys(COOH))-OMe> (the purpose) PolyLys without TEG chains is used as the cationic polymer for preparing PICsomes, and assemblies composed of PolyLys and Alkyne-TEG-bP(Lys(COOH))-OMe are prepared.
[0103] (method) PolyLys and Alkyne-TEG-bP(Lys(COOH))-OMe were synthesized according to the methods of Example 1 (1) and (2). To improve the stability of PICsome particles, PICsomes were crosslinked by a condensation reaction of the polymer side chains using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC). 1s of EDC was added to the carboxyl groups of the side chains of the anionic block copolymer, and the reaction was allowed to proceed for 12 hours. The progress of the crosslinking reaction was monitored by MALDI-TOF MS. NMR spectra showed that the crosslinking rate after the reaction was 28%. After the reaction, the EDC was removed by dialysis. The particle size of the crosslinked PICsomes was then evaluated by dynamic light scattering measurement.
[0104] (result) A 0.1 mM PolyLys solution and a 0.1 mM Alkyne-TEG-bP(Lys(COOH))-OMe solution were mixed and left to stand for 10 minutes, after which dynamic light scattering measurements were performed. As a result, the formation of aggregates with a particle size of about 150 nm was observed (Figure 4).
[0105] The particle size of this polymer increased slightly for about 3 hours after preparation, but did not increase thereafter, and maintained a particle size of about 200 nm even after 12 hours (Figure 4). This was thought to be due to the fact that the removal of the TEG chain from the cationic polymer reduced steric hindrance, resulting in the formation of PICsomes with high particle stability.
[0106] Next, to improve the stability of PICsome particles, PICsomes were crosslinked by a condensation reaction of the polymer side chains using EDC, and then dynamic light scattering (DLS) measurements and field emission scanning electron microscopy were performed. As a result, it was confirmed that aggregates with the same particle size and spherical morphology were formed as before crosslinking. These results suggest that crosslinking of PICsomes while maintaining their particle size and spherical morphology was successful.
[0107] Example 3: Encapsulation of functional molecules inside PICsomes (the purpose) A guest molecule is encapsulated inside the PICsome. In this example, rhodamine-modified neomycin phospho-transferase II (NPTII) (hereinafter referred to as "RhB-NPTII") is used as the guest molecule. NPTII is an enzyme that has the activity of transferring the phosphate group of ATP to the antibiotic kanamycin, and inactivates kanamycin by this activity.
[0108] (method) PICsomes were constructed in the presence of RhB-NPTII to encapsulate RhB-NPTII in the PICsomes. The PICsomes used were composed of PolyLys and Alkyne-TEG-bP(Lys(COOH))-OMe, and the preparation and crosslinking of the PICsomes were carried out according to the method of Example 2. RhB-NPTII that was not encapsulated in the PICsomes was removed by dialysis.
[0109] Next, the incorporation of RhB-NPTII into PICsomes was verified by fluorescence correlation spectroscopy (FCS) and silver staining.
[0110] (result) The diffusion time of RhB-NPTII not encapsulated in PICsomes was measured using fluorescence correlation spectroscopy, and the diffusion time of RhB-NPTII not encapsulated in PICsomes was found to be 0.243 ms.
[0111] Next, the diffusion time of RhB-NPTII encapsulated in PICsomes was measured using fluorescence correlation spectroscopy. The diffusion time of RhB-NPTII encapsulated in PICsomes was 4.86 ms, which was longer than that of RhB-NPTII not encapsulated in PICsomes. This result indicates that RhB-NPTII is encapsulated in PICsomes.
[0112] Furthermore, we performed electrophoresis of RhB-NPTII encapsulated in PICsomes, followed by silver staining and quantification of the protein, and found that approximately 8% of RhB-NPTII was incorporated into PICsomes. These results suggest that RhB-NPTII was successfully encapsulated into PICsome.
[0113] <Example 4: Introduction of cell membrane permeable vesicles into plant tissue> (the purpose) Cell membrane-permeable vesicles encapsulating RhB-NPTII are introduced into root hairs of Arabidopsis thaliana seedlings.
[0114] (method) PICsomes encapsulating RhB-NPTII were prepared according to the method of Example 3. The alkyne presented on the surface of the PICsome encapsulating RhB-NPTII was modified by a click reaction with an azide-containing cell membrane-permeable peptide (CPP), N3-(Lys-Aib-Ala)3 (Aib represents 2-aminoisobutyric acid; sequence number 78), to obtain a PICsome encapsulating RhB-NPTII and presenting a CPP on its surface (hereinafter referred to as a "cell membrane-permeable vesicle").
[0115] Arabidopsis seedlings were immersed in the solution containing the cell membrane-permeable vesicles, and then the pressure was reduced and increased. The red fluorescence derived from rhodamine was then observed by confocal laser scanning microscopy (CLSM) to verify whether the cell membrane-permeable vesicles were introduced into the root hairs. As a control, RhB-NPTII not encapsulated in PICsomes was used.
[0116] (result) After introducing RhB-NPTII not encapsulated in PICsomes into Arabidopsis seedlings, we observed them with a confocal laser microscope. As a result, no red fluorescence derived from RhB was observed in the root hairs of the seedlings (Figure 5, left). Therefore, RhB-NPTII not encapsulated in PICsomes was not introduced into Arabidopsis root hairs.
[0117] Next, we introduced the cell membrane-permeable vesicles encapsulating RhB-NPTII into Arabidopsis seedlings, and observed red fluorescence derived from RhB in the root hairs of the seedlings (Figure 5, right arrow).
[0118] These results demonstrated that RhB-NPTII was successfully delivered to root hairs by using cell membrane-permeable vesicles.
[0119] <Example 5: Genome editing using cell membrane-permeable vesicles> (the purpose) The Cas9-guide RNA complex is encapsulated in a cell membrane-permeable vesicle and introduced into Arabidopsis hypocotyl-derived callus to perform genome editing.
[0120] (method) Polylysine P(Lys-(Boc))-OMe, whose side chains are protected by Boc groups, was linked with ethylenediaminetetraacetic acid dianhydride to synthesize double-stranded polylysine (P(Lys-(Boc))-OMe)2, whose side chains are protected by Boc groups. Alkyne-TEG-b-(P(Lys-(Boc))-OMe)2 was synthesized by linking this with tetraethylene glycol (TEG) having an alkyne. The Boc groups in the side chains of this block copolymer were deprotected with TFA, and then the cationic block copolymer Alkyne-TEG-b-(P(Lys)-OMe)2 was obtained by adding TEA and dialyzing. In addition, the anionic polymer P(Lys(COOH))-OMe was synthesized by reacting the side chains of the cationic polymer PolyLys with succinic anhydride.
[0121] Next, ribonucleoprotein (RNP), which is a complex of Cas9 protein and guide RNA, was encapsulated inside the PICsome. The base sequence of the guide RNA (SEQ ID NO: 77) was designed to specifically recognize and target the base sequence of the phytoene desaturase (PDS) gene. The 1st to 20th bases of the base sequence shown in SEQ ID NO: 77 correspond to the recognition sequence for the target sequence (FIG. 6, "target sequence"). Cas9 protein (Alt-R (registered trademark) Sp Cas9 Nuclease V3; Integrated DNA Technologies, product number 1081059) and guide RNA were mixed and then allowed to stand at room temperature for 10 minutes to obtain RNP, which is a Cas9-guide RNA complex. In the presence of this RNP, an aqueous solution of the polymer was mixed at a ratio of 1:2 and stirred for 10 seconds with a Vortex mixer to construct a PICsome encapsulating RNP, and a PICsome encapsulating RNP was obtained.
[0122] Furthermore, to improve the stability of PICsome particles, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) was used to crosslink the PICsome by condensation of the polymer side chains. The alkyne displayed on the surface of this PICsome was modified by click reaction with an azide-containing cell membrane penetrating peptide (CPP), N3-(Lys-Aib-Ala)3 (SEQ ID NO: 78), to obtain a PICsome (hereinafter referred to as a "cell membrane penetrating vesicle") that encapsulates RNP and displays CPP on its surface.
[0123] Genome editing was performed by introducing this cell membrane permeable vesicle into Arabidopsis hypocotyl-derived callus or true leaves. Specifically, when callus was used, the callus was immersed in an aqueous solution containing the cell membrane permeable vesicle (concentration of each component of the cell membrane permeable vesicle: cationic block copolymer 250 μM and anionic polymer 500 μM), and the pressure was reduced to -0.08 MPa using a vacuum pump (ulvac GLD-051) and a vacuum desiccator (Shinko Kasei V-1), and pressurized to +0.08 MPa using a compact air pump (asone 1-361-02) and a stainless steel pressure vessel (stainless steel tank) (Unicontrols TZA-11-C0671) for 1 minute each. When true leaves were used, the aqueous solution containing the cell membrane permeable vesicle was filled into a needleless syringe, and the solution was discharged while being pressed against the back side of the true leaves to wet them. After two days of incubation, genomic DNA was extracted from the calli or leaves, and the target sequence of the PDS gene was amplified from the genomic DNA by PCR, followed by deep sequencing of the amplified products using a next-generation sequencer.
[0124] (result) Introduction of cell membrane permeable vesicles into callus was performed in three independent experiments. As a result, in one sample, a deletion of one base (Fig. 6(a), "-1"), and a deletion of 14 bases and an insertion of four bases (Fig. 6(c), "-14 / +4") were detected. The number of mutated reads / total number of reads was 6 / 81,677 reads, and the mutation rate was approximately 0.007%.
[0125] Next, the introduction of the cell membrane permeable vesicle into the leaves was performed in three independent experiments. As a result, one base deletion was detected in each of the two samples (Figure 6(a), "-1" and Figure 6(b), "-1"). The number of mutated reads / total number of reads in each trial was 2 / 117,648 reads and 4 / 93,374 reads, and the mutation rates were approximately 0.002% and 0.004%, respectively.
[0126] On the other hand, in three trials using untreated callus that was not treated with cell membrane-permeable vesicles, the number of mutant reads / total number of reads was 0 / 102,764 reads, 0 / 97,757 reads, and 0 / 84,929 reads, respectively, and no mutations were detected at all.
[0127] Mutations induced by genome editing were confirmed in the callus and leaves, indicating that the introduction of RNP into plant tissue using cell membrane-permeable vesicles and the subsequent genome editing were successful.
[0128] In conventional genome editing methods for plants, the Cas9 protein is expressed by inserting a foreign gene encoding the Cas9 protein into genomic DNA using the Agrobacterium method or particle gun method. In this method, the foreign gene introduced into the genomic DNA becomes unnecessary after genome editing. Therefore, it is necessary to obtain null segregants from the progeny, which makes the procedure complicated and takes a long time to complete the series of procedures.
[0129] In contrast, the introduction of a genome editing tool using the cell membrane-permeable vesicle of the present invention makes it possible to directly deliver a genome editing protein without introducing a foreign gene encoding the genome editing protein into genomic DNA, thereby enabling genome editing to be performed easily and in a short period of time.
[0130] The results of this example demonstrated that the cell membrane-permeable vesicle of the present invention actually permeated the cell membrane, migrated into the cell, and reached the genome in the nucleus, and that the delivered functional molecule actually functioned within the cell or nucleus. This result demonstrated that not only genome editing tools but also functional molecules including functional peptides such as enzymes can be delivered into cells by the cell membrane-permeable vesicle of the present invention and function within the cell or nucleus.
[0131] All publications, patents, and patent applications cited herein are hereby incorporated by reference in their entirety.
Claims
1. (a) a polymer comprising a cationic segment formed by linking 3 to 30 lysine residues, the polymer not comprising polyethylene glycol; and (b) A block copolymer comprising an anionic segment formed by linking 3 to 30 carboxylated lysines and an uncharged hydrophilic segment containing polyethylene glycol. A polyion complex vesicle comprising: a cell membrane-permeable peptide displayed on the surface of the polyion complex vesicle and selected from the group consisting of BP100 peptide, BP100(KH)9 peptide, BP100CH7 peptide, and KAibA peptide; A cell membrane-permeable vesicle comprising:
2. The cell membrane-permeable vesicle according to claim 1 , which encapsulates one or more functional molecules.
3. The cell membrane permeable vesicle according to claim 2, wherein the functional molecule is selected from the group consisting of a functional peptide, a functional nucleic acid, and a guide RNA molecule for a Cas9 protein and a target gene.
4. A plant, plant tissue, or plant cell comprising the cell membrane-permeable vesicle according to claim 2 or 3.
5. (a) a polymer comprising a cationic segment formed by linking 3 to 30 lysine residues, and not including polyethylene glycol; and (b) A block copolymer comprising an anionic segment formed by linking 3 to 30 carboxylated lysines and an uncharged hydrophilic segment containing polyethylene glycol. Including, A polyion complex vesicle comprising an alkyne at the end of the polymer and / or the block copolymer.
6. 1. A method for introducing a functional molecule into a cell isolated from a human or a non-human cell, comprising: Contacting the cell with the cell membrane-permeable vesicle according to claim 2 or 3; and applying a physical stimulus to the cell in contact with the cell membrane-permeable vesicle; The method comprising:
7. A method for introducing a mutation into a target gene in a cell isolated from a human or a non-human cell, comprising: Contacting the cell with the cell membrane-permeable vesicle of claim 1 , which harbors a Cas9 protein and a guide RNA molecule for a target gene; and applying a physical stimulus to the cell in contact with the cell membrane-permeable vesicle; The method comprising:
8. The method of claim 6 or 7, wherein the cell is a plant cell.
9. The method of claim 8, wherein the plant cell is a callus or a true leaf plant cell.
10. 1. A method for producing a mutant plant, comprising the steps of: A step of contacting a plant cell with the cell membrane-permeable vesicle according to claim 1 , which encapsulates a Cas9 protein and a guide RNA molecule for a target gene; A step of introducing the cell membrane-permeable vesicle into the plant cell by applying a physical stimulus to the plant cell that has been in contact with the cell membrane-permeable vesicle, thereby introducing a mutation into a target gene; and A step of obtaining an individual plant from the plant cell into which the mutation has been introduced in the previous step. The method comprising:
11. A method for preparing a cell membrane-permeable vesicle encapsulating one or more functional molecules, comprising the steps of: (a) a polymer containing a cationic segment formed by linking 3 to 30 lysine residues as a cationic component, and not containing polyethylene glycol; and (b) a block copolymer comprising an anionic segment formed by linking 3 to 30 carboxylated lysines as an anionic component, and polyethylene glycol; in the presence of a functional molecule to construct a polyion complex vesicle encapsulating the functional molecule; A step of presenting a cell membrane-permeable peptide selected from the group consisting of BP100 peptide, BP100(KH)9 peptide, BP100CH7 peptide, and KAibA peptide on the surface of the polyion complex vesicle. The method comprising:
Citation Information
Patent Citations
Method for transforming with ultrasonic wave
JP2007300915A
Agrobacterium-mediated transformation method and method for producing transformed plant by using the same
JP2012110270A
Exosomes containing therapeutic polypeptides
JP2019520852A
Vesicles for active macromolecule delivery
US20080312134A1
Method of elevating transformation efficiency in plant by adding copper ion
WO2005017152A1
